Symbol: QTFI (Bio) Gehts bald los? 0,03 USD noch? - 500 Beiträge pro Seite
eröffnet am 22.06.04 18:20:49 von
neuester Beitrag 23.06.04 13:44:26 von
neuester Beitrag 23.06.04 13:44:26 von
Beiträge: 7
ID: 872.801
ID: 872.801
Aufrufe heute: 0
Gesamt: 277
Gesamt: 277
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 1 Stunde | 6608 | |
vor 1 Stunde | 5261 | |
vor 57 Minuten | 4419 | |
heute 18:26 | 4052 | |
vor 1 Stunde | 2862 | |
heute 19:32 | 2082 | |
heute 14:53 | 1965 | |
vor 58 Minuten | 1604 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 18.177,89 | +1,38 | 236 | |||
2. | 3. | 0,1855 | -1,85 | 97 | |||
3. | 2. | 1,1800 | -14,49 | 96 | |||
4. | 5. | 9,3600 | +1,24 | 63 | |||
5. | 4. | 167,39 | -1,64 | 57 | |||
6. | Neu! | 0,4250 | -1,16 | 40 | |||
7. | Neu! | 4,8200 | +7,47 | 34 | |||
8. | Neu! | 11,905 | +14,97 | 32 |
(otc) WKN:A0BM03
Könnte ähnlich laufen, wie bei Calypte Bio! Nach dem Reversesplit könnte es spannend werden, so lange die Aktienanzahl nicht wieder verwässert wird!? Der Kurs ist seit einigen Monaten relativ stabil. Die letzten News:
QT 5, Inc. Retains Equitilink LLC for Investor Relations
WESTLAKE VILLAGE, Calif., June 2, 2004 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFI), manufacturer, distributor and marketer of biomedical products, today announced that it has retained Equitilink LLC of La Jolla, Calif. as its investor relations firm.
QT 5, Inc. President, Steven H. Reder said, "Our Company`s corporate development and growth opportunities are at the point where it is appropriate to retain a sophisticated investor relations firm. We are impressed with Equitilink`s broad and proactive relationship with investors who invest in micro cap stocks, and with the extensive and diverse experience of its executives. We believe it is the right firm to advise and assist QT 5, Inc. in our financial communications."
"We believe that QT 5, Inc. has the business plan and the management to succeed at introducing and marketing their full line of diagnostic and first-aid products. We look forward to advising and assisting the company on its financial communications and shareholder relations," said Jim Mahoney, Managing Director of Equitilink LLC. Investors interested in listening to Equitilink`s plan for increasing shareholder value for QT 5, Inc. are encouraged to call Equitilink`s Investor Service Representatives toll-free at 1-877-788-1940.
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: (www.qt5inc.com).
Safe Harbor
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.
Börse NASDAQ OTC BBS
Aktuell 0,035 USD
Zeit 22.06.04 17:02
Diff. Vortag +29,63 %
Tages-Vol. 1.737,50
Geh. Stück 51.000
Geld 0,03
Brief 0,035
Zeit 22.06.04 16:41
Spread 14,286%
Geld Stk. 5.000
Könnte ähnlich laufen, wie bei Calypte Bio! Nach dem Reversesplit könnte es spannend werden, so lange die Aktienanzahl nicht wieder verwässert wird!? Der Kurs ist seit einigen Monaten relativ stabil. Die letzten News:
QT 5, Inc. Retains Equitilink LLC for Investor Relations
WESTLAKE VILLAGE, Calif., June 2, 2004 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFI), manufacturer, distributor and marketer of biomedical products, today announced that it has retained Equitilink LLC of La Jolla, Calif. as its investor relations firm.
QT 5, Inc. President, Steven H. Reder said, "Our Company`s corporate development and growth opportunities are at the point where it is appropriate to retain a sophisticated investor relations firm. We are impressed with Equitilink`s broad and proactive relationship with investors who invest in micro cap stocks, and with the extensive and diverse experience of its executives. We believe it is the right firm to advise and assist QT 5, Inc. in our financial communications."
"We believe that QT 5, Inc. has the business plan and the management to succeed at introducing and marketing their full line of diagnostic and first-aid products. We look forward to advising and assisting the company on its financial communications and shareholder relations," said Jim Mahoney, Managing Director of Equitilink LLC. Investors interested in listening to Equitilink`s plan for increasing shareholder value for QT 5, Inc. are encouraged to call Equitilink`s Investor Service Representatives toll-free at 1-877-788-1940.
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing products. QT 5, Inc. is currently engaged in the development and introduction of Drug Stop, a rapid urinalysis test for drugs of abuse, FDA cleared for professional and over-the-counter use, as well as its Target System(tm) Diagnostic platform that tests for infectious diseases and medical conditions, FDA cleared for professional use only. In addition, the Company markets Xact Aid first-aid products for over-the-counter sales. The company continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: (www.qt5inc.com).
Safe Harbor
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.
Börse NASDAQ OTC BBS
Aktuell 0,035 USD
Zeit 22.06.04 17:02
Diff. Vortag +29,63 %
Tages-Vol. 1.737,50
Geh. Stück 51.000
Geld 0,03
Brief 0,035
Zeit 22.06.04 16:41
Spread 14,286%
Geld Stk. 5.000
"Der Kurs ist seit einigen Monaten relativ stabil."
Hast du eigentlich schon mal auf den Chart geschaut? Stabil ist da nur der Absturz gewesen...
mfg
Money
Hast du eigentlich schon mal auf den Chart geschaut? Stabil ist da nur der Absturz gewesen...
mfg
Money
Ich habe meine ersten zu 0,03 gekauft und zu 0,02.
Der Chart ist bisher recht stabil, andere Werte wie IVHOE z.B magga sind nur am Fallen. (0,0016 USD der Rotz!)
Hier mal anschauen:
http://isht.comdirect.de/charts/big.chart?hist=6m&ind0=VOLUM…
Gruß
can2
otc ist immer riskant!
Der Chart ist bisher recht stabil, andere Werte wie IVHOE z.B magga sind nur am Fallen. (0,0016 USD der Rotz!)
Hier mal anschauen:
http://isht.comdirect.de/charts/big.chart?hist=6m&ind0=VOLUM…
Gruß
can2
otc ist immer riskant!
Kann sein, dass die MMs das Teil noch bis 10 Cents hochzocken, kann aber auch sein, dass dies noch ein letzter kleiner Zock auf dem Weg zu 0,0001 ist.
Es sollen 172,666,667 zusätzliche Aktien auf den Markt geworfen werden...nur will die keiner haben.
Chance: 0,001 %
Chance auf Totalverlust: 99,999 %
Muss jeder selbst wissen.
Gruß,
Fred
QT 5, INC.
172,666,667 SHARES OF COMMON STOCK
This prospectus covers the resale by selling shareholders of up to 172,666,667 shares of our common stock, $0.001 par value. The selling shareholders are offering:
- 166,666,667 shares of common stock underlying our 10% callable secured convertible notes, and
- 6,000,000 shares of common stock underlying warrants.
These securities are more fully described in the section of this prospectus titled " Description of Securities to be Registered" .
The selling shareholders will sell in accordance with the terms described in the section of this prospectus titled " Plan of Distribution" . We will not receive any of the proceeds from the sale of the shares by the selling shareholders.
Our common stock is listed on the Over-The-Counter Bulletin Board. Our trading symbol is " QTFI."
AN INVESTMENT IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD PURCHASE OUR SECURITIES ONLY IF YOU CAN AFFORD A COMPLETE LOSS OF YOUR INVESTMENT. SEE " RISK FACTORS" BEGINNING AT PAGE 2.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus is June __, 2004
http://www.pinksheets.com/quote/news.jsp?url=fis_story.asp%3…
Es sollen 172,666,667 zusätzliche Aktien auf den Markt geworfen werden...nur will die keiner haben.
Chance: 0,001 %
Chance auf Totalverlust: 99,999 %
Muss jeder selbst wissen.
Gruß,
Fred
QT 5, INC.
172,666,667 SHARES OF COMMON STOCK
This prospectus covers the resale by selling shareholders of up to 172,666,667 shares of our common stock, $0.001 par value. The selling shareholders are offering:
- 166,666,667 shares of common stock underlying our 10% callable secured convertible notes, and
- 6,000,000 shares of common stock underlying warrants.
These securities are more fully described in the section of this prospectus titled " Description of Securities to be Registered" .
The selling shareholders will sell in accordance with the terms described in the section of this prospectus titled " Plan of Distribution" . We will not receive any of the proceeds from the sale of the shares by the selling shareholders.
Our common stock is listed on the Over-The-Counter Bulletin Board. Our trading symbol is " QTFI."
AN INVESTMENT IN OUR SECURITIES INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD PURCHASE OUR SECURITIES ONLY IF YOU CAN AFFORD A COMPLETE LOSS OF YOUR INVESTMENT. SEE " RISK FACTORS" BEGINNING AT PAGE 2.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus is June __, 2004
http://www.pinksheets.com/quote/news.jsp?url=fis_story.asp%3…
das ist doch mal ein Argument! Somit sind sie für mich uninteressant geworden! Danke für die Info!
Und der Chart ist trotzdem nicht stabil, außer im Abwärtstrend. Selbst nach dem Re-Split steht die Aktie schon wieder weit jenseits des Abgrundes bzw. liegt schon am Boden. Das Ding eignet sich nicht mal mehr zum zocken - nur noch ein reiner Cash-Burner für die ganz Harten [oder Reichen].
mfg
Money
mfg
Money
wie bitte? Hier mal anschauen:
http://isht.comdirect.de/charts/big.chart?hist=6m&ind0=VOLUM…
die Stimmung ist an den US Märkten echt nicht so dolle und dafür ist der Chart gut im Aufbau! Hallo? Gestern kurz bei 0,04 USD? Chart Top 0,05 USD!
IVHOE ist nach dem Reversesplit von 0,05 USD nun bei 0,0016 USD, das ist abschmiern! Ich rede ja nicht von Euphorie, aber agressiv wurde der Kurs bisher nicht gedrückt?
Entweder ist das Interesse sehr gering oder eine Käuferschicht sammelt vorsichtig ein. Ansonsten würde das Teil weiter Fallen!
Aber ist mir mittlerweile auch egal, otc nervt mich schon ein wenig an. Verwässern ist hier an der Tagesordnung!
Gruß
Can2
http://isht.comdirect.de/charts/big.chart?hist=6m&ind0=VOLUM…
die Stimmung ist an den US Märkten echt nicht so dolle und dafür ist der Chart gut im Aufbau! Hallo? Gestern kurz bei 0,04 USD? Chart Top 0,05 USD!
IVHOE ist nach dem Reversesplit von 0,05 USD nun bei 0,0016 USD, das ist abschmiern! Ich rede ja nicht von Euphorie, aber agressiv wurde der Kurs bisher nicht gedrückt?
Entweder ist das Interesse sehr gering oder eine Käuferschicht sammelt vorsichtig ein. Ansonsten würde das Teil weiter Fallen!
Aber ist mir mittlerweile auch egal, otc nervt mich schon ein wenig an. Verwässern ist hier an der Tagesordnung!
Gruß
Can2
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
237 | ||
110 | ||
100 | ||
65 | ||
55 | ||
39 | ||
34 | ||
32 | ||
29 | ||
25 |
Wertpapier | Beiträge | |
---|---|---|
22 | ||
20 | ||
18 | ||
18 | ||
18 | ||
17 | ||
17 | ||
17 | ||
17 | ||
17 |